Latest raise
$35M
Date raised
November 2, 2026
Round
Series A
InvestorsHatteras Venture Partners
Websitespecificbiologics.com
About Brent Stead
a biotechnology company pioneering a new generation of precision gene-editing therapies for serious genetic diseases
- Who is Brent Stead?
- Brent Stead is listed as Chief Executive Officer at Specific Biologics, a biotechnology company based in Toronto, Canada.
- How much did Specific Biologics raise?
- Specific Biologics raised $35M in a Series A round on November 2, 2026 (1 days ago). Backed by Hatteras Venture Partners.
Get newly funded founders every week
A free weekly list of startups that just raised.